Dean Gilham

1.9k total citations
39 papers, 1.4k citations indexed

About

Dean Gilham is a scholar working on Molecular Biology, Biochemistry and Hematology. According to data from OpenAlex, Dean Gilham has authored 39 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 9 papers in Biochemistry and 8 papers in Hematology. Recurrent topics in Dean Gilham's work include Protein Degradation and Inhibitors (20 papers), Lipid metabolism and biosynthesis (9 papers) and Multiple Myeloma Research and Treatments (6 papers). Dean Gilham is often cited by papers focused on Protein Degradation and Inhibitors (20 papers), Lipid metabolism and biosynthesis (9 papers) and Multiple Myeloma Research and Treatments (6 papers). Dean Gilham collaborates with scholars based in United States, Canada and Germany. Dean Gilham's co-authors include Richard Lehner, Dennis E. Vance, Ewelina Kulikowski, Norman C.W. Wong, Michael Sweeney, Sylwia Wasiak, Laura Tsujikawa, Christopher Halliday, David Y. Hui and Vernon W. Dolinsky and has published in prestigious journals such as Journal of Biological Chemistry, Circulation and Journal of Clinical Investigation.

In The Last Decade

Dean Gilham

38 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dean Gilham United States 20 774 310 296 238 208 39 1.4k
Ahmed Bakillah United States 18 644 0.8× 334 1.1× 238 0.8× 198 0.8× 297 1.4× 47 1.4k
Yu Gu China 21 778 1.0× 98 0.3× 279 0.9× 212 0.9× 80 0.4× 61 1.3k
Mingming Gao China 17 598 0.8× 232 0.7× 286 1.0× 142 0.6× 121 0.6× 76 1.1k
Debra Cromley United States 17 1.1k 1.4× 628 2.0× 938 3.2× 204 0.9× 182 0.9× 22 1.9k
Takashi Terano Japan 18 380 0.5× 359 1.2× 334 1.1× 181 0.8× 204 1.0× 51 1.4k
Iris J. Edwards United States 23 685 0.9× 162 0.5× 311 1.1× 143 0.6× 115 0.6× 32 1.7k
Ken Karasawa Japan 18 413 0.5× 213 0.7× 93 0.3× 121 0.5× 126 0.6× 49 947
Leonardo A. Moraes United Kingdom 21 709 0.9× 169 0.5× 77 0.3× 116 0.5× 100 0.5× 30 1.5k
Masayuki Adachi Japan 24 810 1.0× 201 0.6× 96 0.3× 314 1.3× 142 0.7× 49 1.9k
Takashi Obama Japan 21 429 0.6× 191 0.6× 89 0.3× 137 0.6× 93 0.4× 43 1.1k

Countries citing papers authored by Dean Gilham

Since Specialization
Citations

This map shows the geographic impact of Dean Gilham's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dean Gilham with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dean Gilham more than expected).

Fields of papers citing papers by Dean Gilham

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dean Gilham. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dean Gilham. The network helps show where Dean Gilham may publish in the future.

Co-authorship network of co-authors of Dean Gilham

This figure shows the co-authorship network connecting the top 25 collaborators of Dean Gilham. A scholar is included among the top collaborators of Dean Gilham based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dean Gilham. Dean Gilham is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gilham, Dean, Sylwia Wasiak, Brooke D. Rakai, et al.. (2023). Apabetalone Downregulates Fibrotic, Inflammatory and Calcific Processes in Renal Mesangial Cells and Patients with Renal Impairment. Biomedicines. 11(6). 1663–1663. 6 indexed citations
2.
Wasiak, Sylwia, Li Fu, Dean Gilham, et al.. (2023). The BET inhibitor apabetalone decreases neuroendothelial proinflammatory activationin vitroand in a mouse model of systemic inflammation. Translational Neuroscience. 14(1). 20220332–20220332. 1 indexed citations
3.
Fu, Li, Dean Gilham, Stephanie C. Stotz, et al.. (2023). Dual mechanism: Epigenetic inhibitor apabetalone reduces SARS-CoV-2 Delta and Omicron variant spike binding and attenuates SARS-CoV-2 RNA induced inflammation. International Immunopharmacology. 117. 109929–109929. 2 indexed citations
4.
Wasiak, Sylwia, Dean Gilham, Christopher Halliday, et al.. (2019). Abstract 671: Hepatic Expression of C-Reactive Protein is Epigenetically Regulated by BET Proteins and Inhibited by Apabetalone (RVX-208) in vitro and in CVD Patients. Arteriosclerosis Thrombosis and Vascular Biology. 1 indexed citations
5.
Haarhaus, Mathias, Dean Gilham, Ewelina Kulikowski, Per Magnusson, & Kamyar Kalantar‐Zadeh. (2019). Pharmacologic epigenetic modulators of alkaline phosphatase in chronic kidney disease. Current Opinion in Nephrology & Hypertension. 29(1). 4–15. 18 indexed citations
6.
Jahagirdar, Ravi, Sarah Attwell, Suzana Marušić, et al.. (2017). RVX-297, a BET Bromodomain Inhibitor, Has Therapeutic Effects in Preclinical Models of Acute Inflammation and Autoimmune Disease. Molecular Pharmacology. 92(6). 694–706. 48 indexed citations
7.
Wasiak, Sylwia, Laura Tsujikawa, Christopher Halliday, et al.. (2017). Benefit of Apabetalone on Plasma Proteins in Renal Disease. Kidney International Reports. 3(3). 711–721. 32 indexed citations
8.
Wong, Norman C.W., Ewelina Kulikowski, Cyrus Calosing, et al.. (2017). APABETALONE (RVX-208) LOWERS CARDIOVASCULAR DISEASE (CVD) IN DIABETES MELLITUS BY A MECHANISM INVOLVING MICROBIOME MEDIATED ACTIVITY ON THE COMPLEMENT PATHWAY. Journal of the American College of Cardiology. 69(11). 2009–2009. 1 indexed citations
9.
Wasiak, Sylwia, Dean Gilham, Laura Tsujikawa, et al.. (2016). Data on gene and protein expression changes induced by apabetalone (RVX-208) in ex vivo treated human whole blood and primary hepatocytes. Data in Brief. 8. 1280–1288. 15 indexed citations
10.
Gilham, Dean, Sylwia Wasiak, Laura Tsujikawa, et al.. (2016). RVX-208, a BET-inhibitor for treating atherosclerotic cardiovascular disease, raises ApoA-I/HDL and represses pathways that contribute to cardiovascular disease. Atherosclerosis. 247. 48–57. 88 indexed citations
11.
Castañeda, Tamara R., William Abplanalp, Sung Hee Um, et al.. (2012). Metabolic Control by S6 Kinases Depends on Dietary Lipids. PLoS ONE. 7(3). e32631–e32631. 20 indexed citations
12.
Labonté, Eric D., Juan Camilo Rojas Echeverri, Ronald J. Jandacek, et al.. (2008). Reduced absorption of saturated fatty acids and resistance to diet-induced obesity and diabetes by ezetimibe-treated andNpc1l1−/−mice. American Journal of Physiology-Gastrointestinal and Liver Physiology. 295(4). G776–G783. 96 indexed citations
13.
Hofmann, Susanna M., Li Zhou, Diego Pérez–Tilve, et al.. (2007). Adipocyte LDL receptor–related protein–1 expression modulates postprandial lipid transport and glucose homeostasis in mice. Journal of Clinical Investigation. 117(11). 3271–3282. 134 indexed citations
14.
Wang, Huajin, Dean Gilham, & Richard Lehner. (2007). Proteomic and Lipid Characterization of Apolipoprotein B-free Luminal Lipid Droplets from Mouse Liver Microsomes. Journal of Biological Chemistry. 282(45). 33218–33226. 74 indexed citations
15.
Gilham, Dean, et al.. (2005). Mutation of F417 but not of L418 or L420 in the lipid binding domain decreases the activity of triacylglycerol hydrolase. Journal of Lipid Research. 47(2). 375–383. 20 indexed citations
16.
Gilham, Dean & Richard Lehner. (2005). Techniques to measure lipase and esterase activity in vitro. Methods. 36(2). 139–147. 173 indexed citations
17.
18.
Gilham, Dean & Richard Lehner. (2004). The Physiological Role of Triacylglycerol Hydrolase in Lipid Metabolism. Reviews in Endocrine and Metabolic Disorders. 5(4). 303–309. 20 indexed citations
19.
Dolinsky, Vernon W., Dean Gilham, Grant M. Hatch, et al.. (2003). Regulation of triacylglycerol hydrolase expression by dietary fatty acids and peroxisomal proliferator-activated receptors. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1635(1). 20–28. 31 indexed citations
20.
Veitch, Dallas P., Dean Gilham, & Rosemary B. Cornell. (1998). The role of histidine residues in the HXGH site of CTP :phosphocholine cytidylyltransferase in CTP binding and catalysis. European Journal of Biochemistry. 255(1). 227–234. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ahmed Bakillah Breakdown of academic impact, for papers by Yu Gu Breakdown of academic impact, for papers by Mingming Gao Breakdown of academic impact, for papers by Debra Cromley Breakdown of academic impact, for papers by Takashi Terano Breakdown of academic impact, for papers by Iris J. Edwards Breakdown of academic impact, for papers by Ken Karasawa Breakdown of academic impact, for papers by Leonardo A. Moraes Breakdown of academic impact, for papers by Masayuki Adachi Breakdown of academic impact, for papers by Takashi Obama
Rankless by CCL
2026